{
    "code": 0,
    "data": [
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Results-Financial Results For December 31 2025",
            "news_body": "Unaudited Financial Results for the quarter ended 31st December 2025",
            "news_id": "a1304932-8620-4059-995e-6dd813e06994",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd82a7c8-7072-4b9c-9487-b8bbd502ad57.pdf",
            "news_date": "2026-02-06 19:02:54",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY 2025-26",
            "news_id": "dd087845-517c-4dc2-8969-d4ab74a9dc7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd8b518-8788-471a-9560-fd08aa047c87.pdf",
            "news_date": "2025-11-17 18:39:17",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "2600fc84-5a44-47de-980b-98ac7a3ddfea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c877560-ad45-4116-81f1-5be0ad72b1bb.pdf",
            "news_date": "2025-11-07 17:25:28",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q1 FY 2025-26",
            "news_id": "d95dabd9-1170-4ac5-8268-7c791e76fe32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0fa3838-c22a-4161-a752-fd07d6dfeea1.pdf",
            "news_date": "2025-08-22 13:34:48",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended 30th June 2025",
            "news_id": "f2d96226-0af4-4431-9c76-9428752be016",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91f17f6e-9c19-410d-b1d3-7ca6d21e056a.pdf",
            "news_date": "2025-08-08 18:12:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4 FY 2024-25",
            "news_id": "9bf86f04-b02f-4553-9fa8-4f84576b5563",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d24cdc7-ab86-4104-8bd6-4542bd315f0c.pdf",
            "news_date": "2025-05-29 16:47:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Results - Financial Results For March 31 2025 (Quarter And Year Ended 31/03/2025)",
            "news_body": "Revised Audited Financial Results for quarter and year ended 31st March 2025",
            "news_id": "0cc7ffb6-ee9a-4dfd-9c4d-e12883453fd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e4ca45b-0d9a-49b2-bcb3-01269799dcc1.pdf",
            "news_date": "2025-05-23 21:10:10",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financials Results For The Year Ended 31/03/2025",
            "news_body": "Financials results",
            "news_id": "fb245662-a62a-4bf6-9ee5-e207bdea5c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b8ae44-5952-4478-a901-24e49efd8700.pdf",
            "news_date": "2025-05-23 20:38:31",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For December 31 2024 (Quarter Ended 31St December 2024)",
            "news_body": "Un-Audited Financial Results for the Quarter ended 31st December 2024",
            "news_id": "6b4e36a1-bc4e-4189-a3a1-63377fb0dc9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7f39d8d-1e6b-4316-8da2-f41c61cf0f4e.pdf",
            "news_date": "2025-02-07 18:01:41",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2 FY2024-25",
            "news_id": "e09836b3-b124-4971-a940-3c00d73cdff7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f259f5b3-39f4-4e71-bcd0-c8625d4cfd9e.pdf",
            "news_date": "2024-11-29 16:59:27",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For September 30, 2024",
            "news_body": "Un-audited Financial Results along with Limited Review Report for the Quarter and Half Year ended September 30, 2024.",
            "news_id": "88457964-08bd-470c-86da-097cd97b294e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4617e7e6-9a5c-4b5c-bd4a-63dc76251b29.pdf",
            "news_date": "2024-11-08 16:56:54",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results June 30, 2024 (Quarter Ended)",
            "news_body": "Financial Results for the Quarter ended June, 2024",
            "news_id": "83be4030-614d-4635-b6ef-4a9b18363bdd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a511d49f-05c4-404f-af5f-ee4fc3e39cab.pdf",
            "news_date": "2024-08-09 18:06:15",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Year Ended 31St March, 2024",
            "news_body": "Results for Financial year ended 31st March, 2024",
            "news_id": "ea2f40ba-cb21-4783-9cb7-6c3fb853e784",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0edc406-befe-4542-abcd-7cc69964873e.pdf",
            "news_date": "2024-05-17 18:59:38",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation For Q3 2024.",
            "news_id": "9f4ead8f-8ff7-4401-842a-50d978cac638",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=755e16c4-f9ee-4d98-a151-12ca400c144e.pdf",
            "news_date": "2024-02-19 11:37:15",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31.12.2023",
            "news_body": "Unaudited Financial Results for the quarter ended 31.12.2023",
            "news_id": "b846baef-86c4-4b3e-ae59-e1bb7c5c3958",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d951d028-b3f3-4170-a371-9032fc2d1926.pdf",
            "news_date": "2024-02-09 16:32:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30, 2023",
            "news_body": "Financial Results for the quarter ended 30th September, 2023",
            "news_id": "4556ac96-e487-4c9e-ac2e-fbfce4a1eb54",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d187d2a1-4aec-4820-ab37-3241ad15449e.pdf",
            "news_date": "2023-11-10 16:37:09",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Q1-2024.",
            "news_id": "deb9251c-a959-4d65-ba80-266519e461ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9146a94c-6b49-4f23-b104-2656ef250427.pdf",
            "news_date": "2023-08-21 15:29:36",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30, 2023.",
            "news_body": "Results-Financial Results for June 30,2023.",
            "news_id": "631842c2-3309-42d0-b660-7bb19a906c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0def3c8-06a4-4942-81cf-08a63ab748a1.pdf",
            "news_date": "2023-08-11 16:31:56",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir/Madam,We are enclosing herewith our Company's Investor Presentation for the month of June, 2023.Kindly take the same on record.",
            "news_id": "92a9afdb-8ccf-4814-bb2a-a84924daec6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adf6c347-e68a-427a-89ea-0a98fd957196.pdf",
            "news_date": "2023-06-03 18:59:12",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For March 31, 2023.",
            "news_body": "Results-Financial Results for March 31, 2023.",
            "news_id": "4bd5fe0d-624c-479b-b057-8266a378fdc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=835aa7eb-caca-4772-ab70-0d9bb2b3df91.pdf",
            "news_date": "2023-05-19 16:38:14",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 19Th May, 2023",
            "news_body": "Outcome of Board Meeting dated 19th May, 2023",
            "news_id": "7d1da2cb-fd16-4d35-bda9-482b8b792efe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fb8b4cc-e993-440a-bc04-3bf160f15323.pdf",
            "news_date": "2023-05-19 16:28:24",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 FY2023Dear Sir/Madam,We are enclosing herewith our Company's Investor Presentation for Q3 FY2023.Kindly take the same on record.Thanking you,",
            "news_id": "74eb5e02-30e6-4bac-8fa1-1ef05109a788",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f51402ec-a09d-424d-9734-8982de6ed497.pdf",
            "news_date": "2023-02-17 15:24:38",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended December 31, 2022 Along With Limited Review Report.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended December 31, 2022; and<BR> <BR> 2. Limited Review Report for the quarter ended December 31, 2022.<BR> <BR> You are requested to kindly take the same on record.  <BR> <BR>",
            "news_id": "9fb8b67e-47c1-47bd-b4cb-a0f6ff50df90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddb59cbe-18a6-4f1d-a7f8-c09a0e83dacb.pdf",
            "news_date": "2023-02-10 16:48:34",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 10Th February, 2023.",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 10th February, 2023, inter-alia considered and approved the following agenda Items:<BR> <BR> 1. The Un-Audited Financial Results along with Limited Review Report thereon for the quarter ended 31st December, 2022. <BR> 2. The Board has approved the Resignation of Mr. Lalitkumar P Shah from the post of Director of Anuh Pharma Limited with immediate effect.<BR> <BR> The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 4:15 p.m<BR>",
            "news_id": "0b556ec5-33ae-470e-ad11-ecc5e4d84522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce5174b9-9c90-4a86-b4b1-e7ebf53d6f5e.pdf",
            "news_date": "2023-02-10 16:33:31",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no.  SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 30th  September, 2022.Submitted for your information and records.",
            "news_id": "5865587b-81ef-4bfd-a267-06b75c1728fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f010591b-f809-42b3-99f8-e33aaa4a4cb1.pdf",
            "news_date": "2022-11-15 13:38:28",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended              September 30, 2022 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended,  we are enclosing herewith the following:1. Unaudited Financial Results for the quarter ended September 30, 2022; and2. Limited Review Report for the quarter ended September 30, 2022",
            "news_id": "9adfa23b-aa0c-40fb-bad3-e615f66d4c3d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68ed0960-9832-4fdb-9493-930a1d582bd0.pdf",
            "news_date": "2022-11-07 15:46:08",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 7Th November, 2022",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Monday, 7th November, 2022, inter-alia considered and approved the following agenda Items: <BR> <BR> 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th September, 2022. <BR> <BR> <BR> The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM<BR>",
            "news_id": "fb4b361d-7066-4d2a-a94f-56583d22f1de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0f4dbca-2829-4b43-8de7-da0025085958.pdf",
            "news_date": "2022-11-07 15:32:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are enclosing herewith our Company's Investor Presentation for Q1 FY2023.",
            "news_id": "227253ef-6c0c-4b49-a936-c9accbe02f55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0411809c-4a6a-4c7c-91c0-85d0bda50783.pdf",
            "news_date": "2022-08-09 12:11:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended June 30, 2022; and<BR> <BR> 2. Limited Review Report for the quarter ended June 30, 2022.<BR> <BR> <BR>",
            "news_id": "e9dc433b-c8f2-42e8-895f-4b421c693fbb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b17d0256-1463-4255-8650-513f4217e104.pdf",
            "news_date": "2022-08-05 14:31:30",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 5Th August, 2022",
            "news_body": "Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 5th August, 2022, inter-alia considered and approved the following agenda Items: <BR> <BR> 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2022. <BR>",
            "news_id": "715e5278-6b50-4efc-bf1f-f8af545b3bb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92d2e86d-c36a-4337-8255-4cb05ce1668b.pdf",
            "news_date": "2022-08-05 14:27:27",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, 2022 was discussed.",
            "news_id": "5a7729d7-6639-4e00-a5d9-9f71ec0419b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a571334-c387-4798-b0cc-15e89ab88fa6.pdf",
            "news_date": "2022-05-31 17:44:49",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Conference Call",
            "news_body": "Pursuant to Regulations 30 and 46(2)(ao)  of  SEBI  (Listing  Obligations  and  Disclosure  Requirements) Regulations,  2015, and  with  reference  to  the  subject  cited, please note  that  the  audio recording  of  the  Q4  FY  2022.",
            "news_id": "c08f1067-f797-458a-8e0f-2f3629d1dea0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77970918-d14e-423a-b422-d2d23b05639f.pdf",
            "news_date": "2022-05-30 18:31:24",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular bearing reference no.  SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 31st March, 2022.",
            "news_id": "e1dbb871-03ca-4464-8925-6bd4160638cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6b34475-1538-4a75-87e9-4c9ff04257ca.pdf",
            "news_date": "2022-05-27 17:37:02",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s Investor Presentation for the month of May, 2022.",
            "news_id": "d26a80a4-523b-4994-98a7-d6d2f4724d5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5765d5d-1c06-4d1f-96dd-ed05c590f54f.pdf",
            "news_date": "2022-05-18 18:33:19",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised  Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration",
            "news_body": "With reference to our previous submission dated 14th May, 2022, please find enclosed herewith our revised submission of Audited Financial Results along with Auditor's Report for the year ended 31st March, 2022 & Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022. <BR> <BR>",
            "news_id": "8e585000-0d05-41d4-873f-8c3238aea5db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55c852de-94c8-4990-bc26-6d44b9461d4b.pdf",
            "news_date": "2022-05-16 18:07:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Audited Financial Results for the quarter & year ended March 31, 2022; and<BR> <BR> 2. Auditor''s Report on quarterly financial results and year to date results for the year ended 31st March, 2022; and<BR> <BR> 3. Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022.",
            "news_id": "8964f12c-fb0f-44f1-a8e8-6c35e1a63d7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31aa99ae-e33a-4878-81c0-167fde603e7e.pdf",
            "news_date": "2022-05-14 16:11:05",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 7th February, 2022 at 4.00 PM wherein Financial Performance for Quarter and nine months ended 31st December, 2021 was discussed.",
            "news_id": "fa8186b4-046e-43bc-904a-5ef101285a27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=831f6176-497a-4b33-a016-db2a96cc2446.pdf",
            "news_date": "2022-02-09 15:44:40",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s revised Investor Presentation for the month of February, 2022.",
            "news_id": "9ceca42c-75ed-4a2d-b3af-d5c5ae88fbc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd6b198a-1376-40ab-ba10-9a055bb060a2.pdf",
            "news_date": "2022-02-07 18:06:42",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company''s Investor Presentation for the month of February, 2022.",
            "news_id": "6e88a1db-456d-4dc3-bc0b-e2520eff7a86",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d40c5d3-903c-41d1-8e86-6263cddf9c50.pdf",
            "news_date": "2022-02-07 15:54:13",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter & Nine Months Ended December 31, 2021 Along With Limited Review Report.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter & nine months ended December 31, 2021; and  <BR> <BR> 2. Limited Review Report for the quarter ended December 31, 2021.<BR>",
            "news_id": "8dff668d-da05-4589-8c44-dffcce7bcb15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00b5ace2-66ae-4ab5-a0aa-4d393bb4118d.pdf",
            "news_date": "2022-02-04 17:11:47",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2021",
            "news_body": "Pursuant to the provisions of 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of related party transactions on a consolidated basis for the half year ended September 30, 2021.",
            "news_id": "6e479b31-1466-40c4-8718-8f30f6898b8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=349eb213-cd17-41fe-a7cd-c8c881b25a57.pdf",
            "news_date": "2021-11-20 16:13:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 16th November, 2021 at 4.00 PM wherein Financial Performance for Quarter ended 30th September, 2021 was discussed.",
            "news_id": "5942ddb4-5be8-40bc-bb57-0b803a9f059a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54ed19a8-555d-48ea-8e85-8cff1d5431dc.pdf",
            "news_date": "2021-11-18 14:51:01",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of November, 2021.",
            "news_id": "35e406ed-35cf-4a49-834b-656b2d31429d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554ac8b3-8cda-4509-a652-ecd0661ca25e.pdf",
            "news_date": "2021-11-12 17:54:53",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter & Half Year Ended September 30, 2021 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> 1. Unaudited Financial Results for the quarter & half year ended September 30, 2021; and<BR> 2. Limited Review Report for the quarter ended September 30, 2021.",
            "news_id": "77de18fc-3207-4aef-9d1d-3cb7d23a412b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88f07585-da07-4334-839a-e3e065ffcfcc.pdf",
            "news_date": "2021-11-10 16:00:41",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We are submitting herewith the Transcript of Earnings Audio Conference Call held on 10th August, 2021 at 4.30 PM wherein Financial Performance for Quarter ended 30th June, 2021 was discussed",
            "news_id": "aa38b6a5-b8f7-479c-bbbb-0ab71ed796c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=471c3a21-c171-4907-be1a-f9eff0dce9d7.pdf",
            "news_date": "2021-08-12 14:42:57",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of August, 2021.",
            "news_id": "17deecd8-4114-485b-908f-d0d0c589ebed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8331772d-19c2-4f3e-bafa-d0976140f7f0.pdf",
            "news_date": "2021-08-09 18:35:21",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For The Quarter Ended              June 30, 2021 Along With Limited Review Report",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Unaudited Financial Results for the quarter ended June 30, 2021; and<BR>  <BR> 2. Limited Review Report for the quarter ended June 30, 2021.<BR>",
            "news_id": "6f952635-86dc-4f87-bc64-d0ffe4d3fa1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc6c5950-2f5a-4c06-975e-fbc504a7cada.pdf",
            "news_date": "2021-08-06 16:15:59",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021",
            "news_body": "Pursuant to the provisions of 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of related party transactions on a consolidated basis for the half year ended March 31, 2021.",
            "news_id": "11697c39-95e4-415c-9f8f-5cd94774a6c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3adfc532-a48c-4522-9ea5-18481f45f1d6.pdf",
            "news_date": "2021-06-02 15:10:04",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are submitting herewith our Company's Investor Presentation for the month of May, 2021.",
            "news_id": "f16f4f7f-9447-48fa-af52-73c57456a95b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7044444-dc02-4119-b52c-b23aca99c3ac.pdf",
            "news_date": "2021-05-25 13:14:10",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results Along With Auditor'S Report For The Year Ended March 31, 2021 & Declaration",
            "news_body": "Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following:<BR> <BR> 1. Audited Financial Results for the quarter & year ended March 31, 2021; and<BR> <BR> 2. Auditor's Report on quarterly financial results and year to date results for the year ended 31st March, 2021; and <BR> <BR> 3. Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2021.<BR>",
            "news_id": "46997894-4495-4fa8-8571-9ee70d358f37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37c30e9e-0c28-42f7-b162-842dd664d952.pdf",
            "news_date": "2021-05-21 17:14:06",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ANUHPHR",
            "disp": "Anuh Pharma",
            "bse_code": 506260,
            "isin": "INE489G01022",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Earnings Video Conference Call held on 17th February, 2021 at 4.00 PM to discuss the Financial Performance for Quarter & Nine months 31st December, 2020.",
            "news_id": "9e95b98c-1333-4e30-803f-172ab40cddd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b868232c-3042-434d-a145-5d52a66e9cda.pdf",
            "news_date": "2021-02-19 14:29:55",
            "seo": "anuh-pharma-ltd",
            "ltp": 82.76,
            "ch": -1.2199999999999989,
            "pch": -1.4527268397237423,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 28314,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}